Improving Site-Sponsor Relationships: Proactive Strategies for Transparent Clinical Trials
This eBook outlines how clinical research sites and sponsors can effectively work together to improve their relationship.
Navigating the FDA Emergency Use Filing Process
Partnering with Advarra, one nonprofit successfully obtained an Emergency Use Authorization from the FDA within five weeks.
Didn’t Expect that to Happen: Events that must be Reported Promptly to the IRB
This webinar helps researchers better understand how to evaluate potentially reportable events and what needs to be reported to the IRB.
James Riddle and Willie Muehlhausen Discuss Digital Technology and Virtual Data Collection in Clinical Research
In this episode, we discuss the growth of decentralized clinical trial technology and how IRBs evolved to account for technology advancements.
Improving Patient Centricity and Research Access
There is an increasing challenge to find eligible patients and build trial awareness, so how should the industry address them?
For FDA Inspection Readiness, Accountability is Key
An Advarra expert provides insight in this Q&A session on the FDA inspection readiness process, including how to improve current workflows.
Study Startup Support Info Sheet
Advarra provides flexible solutions that help accelerate the initial IRB review process and make it more efficient.
Top 10 Educational Resources of 2021
In this blog, we take a look at popular blog posts and webinars in 2021 garnering the most interest from research community members like you.
Q&A: FDA Updates: BIMO – What Sponsors Need to Know
Advarra experts Joan Versaggi and Leslie Paul answer questions from the webinar- FDA Updates: BIMO – What Sponsors Need to Know.
The Key to Increasing Diversity in Decentralized Trials
Rosamund Round VP of Parexel’s Patient Innovation Center and DCTs shares key strategies for increasing diversity in decentralized trials.
Unique Ethical Issues in Phase I Oncology Studies
An essential step in research, Phase I oncology studies raise unique ethical challenges for sponsors, investigators, and IRBs.
Returning to In-person Work: Sponsor Versus Site Viewpoints
An Advarra Trend Report found sites and sponsors alike are facing shifts as they continue to navigate the pandemic.